Can maitake MD-fraction aid cancer patients?

  title={Can maitake MD-fraction aid cancer patients?},
  author={Noriko Kodama and Kiyoshi Komuta and Hiroaki Nanba},
  journal={Alternative medicine review : a journal of clinical therapeutic},
  volume={7 3},
Maitake mushroom (Grifola frondosa) MD-fraction containing beta-1,6 glucan with beta-1,3 branched chains has previously exhibited strong anticancer activity by increasing immune-competent cell activity.1,2 In this non-random case series, a combination of MD-fraction and whole maitake powder was investigated to determine its effectiveness for 22- to 57-year-old cancer patients in stages II-IV. Cancer regression or significant symptom improvement was observed in 58.3 percent of liver cancer… CONTINUE READING
Highly Cited
This paper has 53 citations. REVIEW CITATIONS
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 18 extracted citations

54 Citations

Citations per Year
Semantic Scholar estimates that this publication has 54 citations based on the available data.

See our FAQ for additional information.